Insilico Medicine与Human Longevity已结成合作伙伴关系，共同开发能够提前数十年预测疾病的AI模型。此次合作旨在通过整合Insilico的AI算法与Human Longevity的海量基因组数据，来推进个性化健康研究。这项被描述为数百万美元的联合开发项目，预计将加速新型长寿药物的发现。 AI
影响 此次合作有望加速新型长寿药物的发现，并推进个性化健康研究。
排序理由 两家公司合作开发用于疾病预测的AI。[lever_c_demoted from significant: ic=1 ai=0.7]
AI 生成摘要 · Google Gemini · 来自 2 个来源。 我们如何撰写摘要 →
Hong Kong-listed artificial intelligence drug-discovery company Insilico Medicine has struck a collaboration with US-headquartered Human Longevity to co-develop what they describe as “the industry’s first large-scale” AI foundation models capable of predicting diseases – such as …
Insilico Medicine, the Hong Kong-listed AI drug discovery company, has teamed up with US-based Human Longevity to build what they call the industry first large-scale AI foundation models capable of predicting diseases like cancer decades before clinical symptoms appear. The partn…